ACT-709478

· Idorsia Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-709478, covering 2018-08-31 to 2018-08-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients [Phase 2]